20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16776 | RO9021 | Syk | |
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM). | |||
T4209 | TAK-659 hydrochloride | TAK-659 | VEGFR , FLT , Tyrosine Kinases , JAK , Syk |
TAK-659 hydrochloride (TAK-659) is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM. It is selective against most other kinases, but potent toward both SYK and FLT3. | |||
T39437 | Cevidoplenib dimesylate | Syk | |
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties. | |||
T14331 | Gusacitinib | ASN-002 | JAK , Syk |
Gusacitinib (ASN-002) (ASN-002) is spleen tyrosine kinase (SYK) and janus kinase (JAK) inhibitor (IC50: 5-46 nM). | |||
T11824LL | Lanraplenib | GS-9876 | Syk |
Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI ... | |||
T6101 | Entospletinib | GS-9973 | Syk |
Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable. | |||
T6115 | Fostamatinib | R788 | FLT , Syk , Monoamine Transporter , Adenosine Receptor |
Fostamatinib (R788)(IC50 of 41 nM), which is a prodrug of the active metabolite R406, is a Syk inhibitor. It does not work on Lyn. | |||
T6594 | MNS | Syk , Src , p97 | |
MNS is a tyrosine kinases inhibitor, inhibits Syk, Src, p97 with IC50 of 2.5 μM, 29.3 μM and 1.7 μM, respectively. | |||
T6174 | R406 | R-406 besylate | Apoptosis , FLT , Syk |
R406 (R-406 besylate) is an effective Syk inhibitor (IC50: 41 nM) and shows no effects on Lyn. | |||
T4348 | Syk Inhibitor II | 5-HT Receptor , Syk | |
Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM). | |||
T2467 | R406 free base | R406 (free base) | Apoptosis , FLT , Syk |
R406 free base (R406 (free base)) is a potent Syk inhibitor. | |||
T0610 | Piceatannol | trans-Piceatannol,Astringenin | Apoptosis , Serine/threonin kinase , PKA , Syk , PKC , Autophagy |
Piceatannol (Astringenin) is an anti-inflammatory, immunomodulatory and antiproliferative agent. It inhibits p56lck and syk protein tyrosine kinases and inhibits NF-κB activation and gene expression of TNF-induced. It is... | |||
T2487 | Cerdulatinib | PRT2070,PRT062070 | Tyrosine Kinases , JAK , Syk |
Cerdulatinib (PRT2070) is an novel oral dual Syk/JAK inhibitor. | |||
T3185 | R112 | (E)-Elafibranor | Syk |
R112 ((E)-Elafibranor) is an ATP-competitive inhibitor of Syk kinase. | |||
T2605 | Fostamatinib Disodium | Tamatinib Fosdium,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium | FLT , Syk |
Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. | |||
T6776 | BAY 61-3606 dihydrochloride | BAY 61-3606,BAY-61-3606 dihydrochloride | Apoptosis , Syk |
BAY 61-3606 dihydrochloride (BAY 61-3606) is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM). | |||
T6957 | PRT-060318 | P142-76,PRT318,PRT-060318 2HCl | Syk |
PRT-060318 (P142-76) is a novel selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment. | |||
T2696 | PRT062607 hydrochloride | PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride | MLK , Syk , Src |
PRT062607 hydrochloride (P505-15 Hydrochloride) is a selective inhibitor of Syk (IC50: 1 nM). It displays at least 80-fold selectivity for Syk over other kinases. | |||
T4263 | BAY 61-3606 | Syk inhibitor IV | Apoptosis , Syk |
BAY 61-3606 (Syk inhibitor IV) is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM), exhibiting no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src. | |||
T6104 | Cerdulatinib hydrochloride | Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride | MLK , c-Fms , Tyrosine Kinases , Hippo pathway , JAK , Syk |
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19... |